Back
Design Therapeutics Stock Price Chart
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free
Sell
1
DSGN
Design Therapeutics
Last Price:
$4.52
Seasonality Move:
-3.47%
7 Day Trial
ALL ACCESS PASS
$
7
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DSGN is experiencing selling pressure, which indicates risk of future bearish movement.
Design Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.87 | Sell |
| 20-day SMA: | 6.08 | Sell |
| 50-day SMA: | 6.01 | Sell |
| 200-day SMA: | 4.8 | Sell |
| 8-day EMA: | 5.65 | Sell |
| 20-day EMA: | 5.95 | Sell |
| 50-day EMA: | 5.91 | Sell |
| 200-day EMA: | 5.07 | Sell |
Design Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 31.55 | Sell |
| Chaikin Money Flow: | -179854 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.67 - 6.63) | Sell |
| Bollinger Bands (100): | (4.98 - 6.22) | Sell |
Design Therapeutics Technical Analysis
| Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Design Therapeutics Stock
Is Design Therapeutics Stock a Buy?
-
Design Therapeutics share price is 4.52 while DSGN 8-day simple moving average is 5.87, which is a Sell signal.
-
The stock price of DSGN is 4.52 while Design Therapeutics 20-day SMA is 6.08, which makes it a Sell.
-
Design Therapeutics 50-day simple moving average is 6.01 while DSGN share price is 4.52, making it a Sell technically.
-
DSGN stock price is 4.52 and Design Therapeutics 200-day simple moving average is 4.80, creating a Sell signal.
DSGN Technical Analysis vs Fundamental Analysis
Sell
1
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy or a Sell?
-
Design Therapeutics stock is rated a SellThe current Design Therapeutics [DSGN] share price is $4.52. The Score for DSGN is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
Design Therapeutics Stock Info
Market Cap:
255.9M
Price in USD:
4.52
Share Volume:
293.4K
Design Therapeutics 52-Week Range
52-Week High:
7.77
52-Week Low:
2.25
Sell
1
Design Therapeutics (DSGN)
is a Sell
Design Therapeutics Share Price Forecast
-
What is the Design Therapeutics stock price today?The Design Therapeutics stock price is 4.52 USD today.
-
Will DSGN stock go up or go down?Design Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Design Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics is overvalued.
Is Design Therapeutics Stock a Buy?
-
Design Therapeutics share price is 4.52 while DSGN 8-day exponential moving average is 5.65, which is a Sell signal.
-
The stock price of DSGN is 4.52 while Design Therapeutics 20-day EMA is 5.95, which makes it a Sell.
-
Design Therapeutics 50-day exponential moving average is 5.91 while DSGN share price is 4.52, making it a Sell technically.
-
DSGN stock price is 4.52 and Design Therapeutics 200-day simple moving average is 5.07, creating a Sell signal.
Fundamental Analysis of Design Therapeutics
Is Design Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.07 per share.
Technical Analysis of Design Therapeutics
Should I short Design Therapeutics stock?
-
DSGN Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Design Therapeutics is a Sell
-
Design Therapeutics Relative Strength Index (RSI) is 31.55, which suggest Design Therapeutics is oversold
-
The Bollinger Bands (25) for Design Therapeutics is (5.67 - 6.63), which suggest Design Therapeutics is a Sell
-
The Bollinger Bands (100) for Design Therapeutics is (4.98 - 6.22), which suggest Design Therapeutics is a Sell
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.